CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
42 hedge funds and large institutions have $130M invested in Carisma Therapeutics in 2014 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 13 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
15% less capital invested
Capital invested by funds: $153M → $130M (-$22.7M)
Holders
42
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$1.56M | |
| 2 | +$1.25M | |
| 3 | +$618K | |
| 4 |
Goldman Sachs
New York
|
+$187K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$184K |
Top Sellers
| 1 | -$2.37M | |
| 2 | -$127K | |
| 3 | -$75.8K | |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$53.2K |
| 5 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
-$50.3K |